Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline (scientific article published on 01 January 2020)

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Q27861020

Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial

Q34439105

The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update

Q34603491

Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults.

Q35103169

The metabolic syndrome and cognitive performance: the Northern Manhattan Study

Q35546438

The Relationship between Metabolic Syndrome and Cognitive Function.

Q36058383

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms

Q37767097

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Q39976878

Metabolic syndrome and cognitive decline in French elders: the Three-City Study.

Q51021196

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

Q52539745

A new rating scale for Alzheimer's disease.

Q53197509

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Q53316862

Metabolic Syndrome and cognitive decline in the elderly: A systematic review.

Q54961329

Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism